Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients (NCT05431491) | Clinical Trial Compass
CompletedNot Applicable
Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients
United Kingdom18 participantsStarted 2022-08-12
Plain-language summary
To determine the feasibility and safety of deresuscitation using slow continuous ultrafiltration with regional citrate anticoagulation and peripheral or standard central venous access.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults (\>18 years)
* Evidence of fluid overload (greater than trace amount of peripheral oedema in \>1 site, pulmonary oedema on chest radiograph, or positive fluid balance equivalent to \>5% body weight)
* Clinician intention to target a negative fluid balance
* Expected to remain in a critical care setting beyond the next calendar day
Exclusion Criteria:
Anticipated unavailability of suitable vascular access
* Lack of commitment to full support
* Receiving or imminently planned to receive renal replacement therapy
* Hyponatraemia (Sodium \<130mmol/L)
* Hypernatraemia (Sodium \>150mmol/L)
* Significant metabolic alkalosis (Bicarbonate\>30 and pH\>7.5)
* Significant metabolic acidosis (HCO3- \<18 mmol/l and pH \< 7.30)
* Uncorrected hypokalaemia (Potassium \<3.0mmol/L)
* Liver failure (Child-Pugh Grade B or above)
* Shock (any of: lactate \>3mmol/L, extensive skin mottling, central capillary refill time\>3 seconds, more than 1 vasoactive agent in use, noradrenaline dose \>0.2 mcg/kg/min, use of dobutamine, adrenaline, milrinone, enoximone or levosimendan)
* Receiving any systemic anticoagulation other than for routine venous thromboembolism prophylaxis, or dual antiplatelet therapy
* Prisoner
* Known pregnancy
What they're measuring
1
Number of patients with daily fluid balance within 500 mL of prescribed target
Timeframe: 5 days per patient
2
Number of patients with filter or circuit thrombosis requiring discontinuation of therapy
Timeframe: 5 days per patient
3
Total volume of fluid removed using ultrafiltration